Lipertance

Amlodipine besilate / Perindopril arginine / Atorvastatin calcium, the active ingredient in Lipertance, is a combination antihypertensive and lipid‑lowering drug presented as a combination tablet for oral use. It treats hypertension and hyperlipidemia in adult patients.

GNH USA supplies Lipertance as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lipertance is indicated for conditions involving elevated blood pressure and abnormal lipid levels. - Hypertension: helps lower systolic and diastolic blood pressure. - Hyperlipidemia: reduces LDL‑cholesterol and total cholesterol. - Cardiovascular risk reduction: contributes to lowering overall risk of cardiovascular events in patients with both hypertension and dyslipidemia.

Adverse reactions reported with Lipertance reflect the known safety profiles of its three components.

Common Side Effects: - Headache: mild to moderate headache. - Dizziness: transient dizziness, especially after first dose. - Peripheral edema: swelling of ankles or feet. - Gastrointestinal discomfort: nausea, abdominal pain or dyspepsia.

Serious or Rare Side Effects: - Angioedema: swelling of face, lips, tongue or airway. - Severe liver injury: marked elevation of transaminases or jaundice. - Myopathy or rhabdomyolysis: muscle pain with elevated CK, especially with atorvastatin. - Hyperkalemia: elevated potassium levels due to ACE inhibition.

Before prescribing Lipertance, clinicians should consider the following precautions. - Renal impairment: adjust dose and monitor renal function in patients with reduced kidney function. - Hepatic disease: avoid or use with caution in patients with active liver disease; monitor liver enzymes. - Pregnancy: contraindicated or not recommended during pregnancy; discuss risks with women of childbearing potential. - Concomitant potassium‑sparing diuretics: monitor serum potassium to avoid hyperkalemia. - Drug hypersensitivity: discontinue if signs of allergic reaction such as rash or angioedema appear. - Store at ambient temperature: keep below 25°C in original packaging, protect from moisture and light.

Lipertance may interact with several medicines; awareness of major and moderate interactions helps prevent adverse outcomes.

Major Interactions (Avoid): - ACE inhibitor with potassium‑rich supplements or spironolactone: risk of severe hyperkalemia. - Strong CYP3A4 inhibitors (e.g., clarithromycin, itraconazole): increase atorvastatin exposure, raising risk of myopathy. - Simultaneous use of other calcium‑channel blockers: additive hypotensive effect. - Nitrates: may cause excessive vasodilation and hypotension.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): may reduce antihypertensive efficacy and affect renal function. - Diuretics: may enhance hypotensive effect; monitor blood pressure and electrolytes. - Antacids containing aluminum or magnesium: may reduce absorption of amlodipine; separate dosing by at least 2 hours.